Abstract Library
Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.
Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.
ENETS Abstract Search
Introduction: We compared TACE and TAE in patients with pancreatic (pNET) or small-intestine NET (siNET) and explored the role of biomarkers related to alkylating agents (O6-methylguanine-methyltransferase [MGMT], alkylpurine–DNA–N-glycosylase [APNG]) or hypoxia (Carbonic anhydrase IX [CAIX]).
Conference:
Presenting Author: de Mestier L
Authors: Vedie A, Dioguardii Burgioo M, Matteini F, Akez M, Hentic O,
Keywords: transarterial embolization, chemoembolization, metastatic neuroendocrine tumor, biomarker,
#3243 The major impact of proGRP monitoring in advanced atypical lung carcinoid: A case report
Introduction: Atypical lung carcinoids (aLC) are more aggressive than typical carcinoids, metastasizing more commonly to distant sites, and require vigilant follow-up. However, the surveillance is often hampered by the non-informative Chromogranin A (CgA) levels.
Conference: 18th Annual ENETS Concerence (2021)
Presenting Author:
Authors: Oleinikov K, Ben-Haim S, Atlan K, Nisman B, Bloom A,
Keywords: pro-GRP, lung carcinoids, biomarker,
Introduction: Sequential Transarterial Chemoembolization (TACE) may be considered repetitively during the course of the disease. However, evaluation methods remain controversial.
Conference: 18th Annual ENETS Concerence (2021)
Presenting Author:
Authors: Touloupas C, Faron M, Deschamps F, Hadoux J, Roux C,
Keywords: neuroendocrine, liver metastases, chemoembolization, intra-arterial therapies, mRECIST,
#2835 Primary Hepatic Neuroendocrine Carcinoma: Case Report and Literature Review
Introduction: Primary hepatic neuroendocrine carcinoma (PHNEC) is an extremely rare neuroendocrine carcinoma (NEC) that originate from the liver. The diagnosis of PHNEC remains challenging because of its rarity, and its lack of unique clinical features. Available treatment options for PHNEC include surgical resection of the liver tumor(s), radiotherapy, liver transplant, transcatheter arterial chemoembolization (TACE), and administration of somatostatin analogues.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Keywords: primary hepatic neuroendocrine carcinoma, liver biopsy, immunohistochemical staining, Somatostatin analogue,
Introduction: Selective transarterial embolization(TAE) and chemoembolization(TACE),are alternative options to systemic therapies in patients with GEP-NET G1/G2 with advanced locoregional disease and/or unresectable liver metastases
Conference: 14th Annual ENETSConcerence (2017)
Presenting Author:
Authors: Blanco C, Crespo E, Gamo M, Villalobos L, Escribano P,